Femasys shares rise 10.96% intraday after Nasdaq grants 180-day extension to meet $1 bid price requirement.

Femasys Inc. (NASDAQ: FEMY) surged 10.96% intraday after being granted a 180-day extension by Nasdaq to meet the minimum bid price requirement. The extension, announced on January 13, 2026, extends compliance efforts until July 13, 2026, with the company planning potential actions such as a reverse stock split to address the $1.00 bid price threshold. Nasdaq confirmed Femasys remains in compliance with all other listing criteria, including market value of publicly held shares. The news alleviated immediate delisting risks and signaled regulatory flexibility, boosting investor confidence. The extension allows the company time to stabilize its share price, aligning with its ongoing commercialization efforts for products like FemBloc and FemaSeed. The positive reaction reflects optimism that the additional timeframe will enable compliance and sustain market viability.